Related Experiment Videos
Recurrent Salmonella meningitis in a compromised host
Abstract:
A 26-year-old woman with Hodgkin's disease had recurrent episodes of meningitis caused by Salmonella enteritidis serotype poona, which responded well to antimicrobial therapy. An extensive investigation failed to reveal a focus of infection. A defective cellular immune response and the intracellular location of these microorganisms probably accounted for the pattern of infection seen in this patient. The need for long-term therapy in compromised patients with this type of infection is stressed.
Insights
A woman with Hodgkin's disease experienced recurrent Salmonella meningitis. Her infection was likely due to a weakened immune system, highlighting the need for long-term treatment in immunocompromised patients.
Area of Science:
- Infectious Diseases
- Immunology
- Oncology
Background:
- Hodgkin's disease can compromise the immune system, increasing susceptibility to infections.
- Recurrent meningitis poses a significant health risk, particularly in immunocompromised individuals.
Observation:
- A 26-year-old female patient with Hodgkin's disease presented with recurrent meningitis.
- The meningitis was caused by Salmonella enteritidis serotype poona and initially responded to antimicrobial therapy.
- Despite extensive investigation, the primary source of infection remained unidentified.
Findings:
- The recurrent Salmonella meningitis is attributed to a defective cellular immune response in the patient.
- The intracellular nature of Salmonella enteritidis serotype poona contributes to the persistent infection pattern.
- Antimicrobial therapy was effective in managing acute episodes but did not prevent recurrence.
Implications:
- Patients with compromised immune systems, such as those with Hodgkin's disease, require careful monitoring for opportunistic infections.
- Long-term antimicrobial therapy may be necessary for managing recurrent infections caused by intracellular pathogens in immunocompromised individuals.
- This case underscores the importance of considering immune status when managing infectious diseases.